Is ketorolac (Nonsteroidal Anti-Inflammatory Drug (NSAID)) safe to use in patients with asthma?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: June 7, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Ketorolac should be used with caution in patients with asthma due to the risk of bronchospasm. According to the study 1, asthma can be exacerbated by certain drugs, such as nonsteroidal anti-inflammatory drugs (NSAIDs), which includes ketorolac. The mechanism behind this reaction involves the inhibition of cyclooxygenase enzymes, which shifts arachidonic acid metabolism toward the lipoxygenase pathway, increasing production of leukotrienes that can trigger bronchospasm. Some key points to consider when using ketorolac in patients with asthma include:

  • If a patient has a known history of NSAID-induced asthma exacerbations, ketorolac is contraindicated.
  • For patients with stable asthma and no history of NSAID sensitivity, ketorolac may be used with careful monitoring for respiratory symptoms.
  • The lowest effective dose of ketorolac should be used, typically 10mg orally or 15-30mg IM/IV.
  • Patients should be monitored closely for wheezing or shortness of breath, and have rescue medications readily available.
  • Alternative pain medications like acetaminophen or certain opioids may be safer options for asthmatic patients with known NSAID sensitivity. It's also important to note that aspirin-sensitive asthma is frequently associated with a genetic sequence variation and is relatively common in Eastern Europe and Japan, as mentioned in the study 1.

From the FDA Drug Label

Ketorolac tromethamine should not be given to patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs. Severe, rarely fatal, anaphylactic-like reactions to NSAIDs have been reported in such patients Patients with asthma may have aspirin-sensitive asthma The use of aspirin in patients with aspirin-sensitive asthma has been associated with severe bronchospasm which can be fatal Since cross reactivity, including bronchospasm, between aspirin and other non-steroidal anti-inflammatory drugs has been reported in such aspirin-sensitive patients, ketorolac tromethamine should not be administered to patients with this form of aspirin sensitivity and should be used with caution in patients with preexisting asthma

Ketorolac is not safe to use in patients with asthma, especially those with aspirin-sensitive asthma, due to the risk of severe bronchospasm and anaphylactic-like reactions 2, 2.

  • Contraindication: Ketorolac tromethamine is contraindicated in patients who have experienced asthma, urticaria, or allergic-type reactions after taking aspirin or other NSAIDs.
  • Preexisting Asthma: Patients with preexisting asthma should be used with caution when taking ketorolac tromethamine.

From the Research

Safety of Ketorolac in Asthma Patients

  • Ketorolac is a Nonsteroidal Anti-Inflammatory Drug (NSAID) that can precipitate bronchospastic- and anaphylactic-type life-threatening reactions in some patients, including those with asthma 3.
  • The use of ketorolac is contraindicated in patients with a history of aspirin and NSAID intolerance, asthma, rhinitis, and nasal polyps 3.
  • When administering ketorolac to asthmatics, it should be done with extreme caution and monitoring, especially when the intramuscular preparation is used 3.

Alternative Treatment Options

  • Celecoxib, a highly selective COX-2 inhibitor, has been shown to be safe in patients with aspirin-induced asthma 4.
  • Inhaled corticosteroids are the preferred monotherapy for patients with persistent asthma, and have been shown to be more effective than anti-leukotrienes in preventing exacerbations and improving lung function 5.

Management of Asthma Exacerbations

  • Acute asthma exacerbations can be triggered by various factors, including NSAIDs like ketorolac 6.
  • The management of asthma exacerbations involves the use of short-acting β2-agonists, inhaled corticosteroids, and other controller medications, as well as the avoidance of aggravating environmental factors 7, 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Ketorolac-precipitated asthma.

Southern medical journal, 1994

Research

Celecoxib, a highly selective COX-2 inhibitor, is safe in aspirin-induced asthma patients.

Journal of investigational allergology & clinical immunology, 2003

Research

Mechanisms and Management of Asthma Exacerbations.

American journal of respiratory and critical care medicine, 2019

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.